Welcome to our dedicated page for Aar SEC filings (Ticker: AIR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AAR Corp’s maintenance, repair, overhaul, and defense-logistics work touches thousands of aircraft and sensitive government missions—so its SEC paperwork is anything but light reading. Tracking segment margins, contract backlogs, or expeditionary airlift exposure across a 300-page annual report can stall timely decisions. If you have ever searched for “AAR Corp SEC filings explained simply� or wondered how “AAR Corp insider trading Form 4 transactions� affect valuation, you know the challenge.
Stock Titan solves it. Our AI models read every AAR Corp quarterly earnings report 10-Q filing and annual report 10-K simplified, surfacing revenue by segment, supply-chain risks, and key footnotes in plain language. Need real-time alerts? You will see “AAR Corp Form 4 insider transactions real-time� moments after they hit EDGAR, alongside concise context on executive stock transactions Form 4. Material contract wins and fleet-service extensions are tagged inside each 8-K, giving you “AAR Corp 8-K material events explained� without sifting through legal prose.
Whether you are comparing operating-cash trends quarter over quarter, reviewing “AAR Corp proxy statement executive compensation�, or seeking in-depth “AAR Corp earnings report filing analysis�, our platform keeps every filing type�10-K, 10-Q, 8-K, DEF 14A, Forms 3/4/5—updated the moment they post. Powerful AI summaries, searchable text, and exportable tables mean understanding AAR Corp SEC documents with AI takes minutes, not hours. Make confident calls on insider sentiment, parts-supply inventory cycles, and defense contract health—without getting lost in the paperwork.
AC Immune SA (ACIU) has filed a Form 144 notice stating that an insider intends to sell up to 20,000 common shares through Morgan Stanley Smith Barney beginning on 24 Jul 2025. The proposed sale, valued at roughly $46,800, stems from stock options exercised on 1 Jun 2012. With 100.41 million shares outstanding, the transaction equals only about 0.02 % of the float. No other insider sales by this filer occurred during the past three months.
Form 144 is a preliminary notice and does not obligate the seller to complete the trade; it simply satisfies SEC Rule 144 requirements for resales of restricted or control securities. Given the modest size, the filing is unlikely to affect liquidity or pricing materially and appears to be a routine portfolio-management move rather than a signal about AC Immune’s operating outlook.
AAR Corp. (AIR) filed a Form 144 disclosing a proposed Rule 144 sale of 7,262 common shares through Morgan Stanley Smith Barney on or about 07/23/2025. The shares were acquired the same day via stock-option exercise under a registered plan and will be sold for an estimated $559,740 based on the filing’s stated market value.
The proposed sale represents roughly 0.02% of AIR’s 35.8 million shares outstanding, indicating a modest transaction size. No prior insider sales were reported in the past three months, and the filer certifies no undisclosed material adverse information. While any insider sale can raise questions about sentiment, the limited size and option-exercise origin suggest a routine liquidity event rather than a strategic divestiture.
ALT5 Sigma Corporation (NASDAQ: ALTS) filed an 8-K announcing the May 9 2025 acquisition of “Mswipe,� a Canada-based provider of multi-currency, fiat- and crypto-enabled payment card solutions available on Visa and Mastercard networks.
- Strategic rationale: Mswipe’s B2B platform extends ALT5’s existing digital-asset settlement offering by adding globally usable physical & virtual cards, real-time FX/crypto conversion and robust compliance.
- Consideration: (i) 1 million restricted ALTS shares valued at $6.10 each (~$6.1 M); (ii) 500 k four-year warrants exercisable at $5.50; (iii) $4.8 M in shares of spin-off Alyea Therapeutics; (iv) two 14-month promissory notes totalling ~$1 M at 3.99% interest; and (v) assumption/reset of an existing $5.1 M target-level note.
- Contingent payout: Sellers may receive a one-time earn-out of up to $20 M (cash or stock) if the operating subsidiaries reach �$15 M annualised or actual revenue.
- Audited FY25/FY24 Mswipe financials (Ex. 99.1) and unaudited pro-forma combined statements (Ex. 99.2) were filed; a press release (Ex. 99.3) was issued on May 13 2025.
No immediate revenue or EPS guidance was provided. The transaction is expected to close seamlessly as ALT5 integrates card issuance, aiming to bridge digital assets with traditional payment rails.
Nature's Sunshine Products (NATR) � Insider Form 4
EVP & General Counsel Nathan G. Brower reported an automatic share withholding on 21 Jul 2025. The filing (Transaction Code F) shows 1,491 common shares withheld at $14.80 to cover taxes triggered by the vesting of restricted stock units granted on 21 Jul 2022. After the transaction, Brower directly owns 58,273 NATR shares. Because Code F represents a tax-payment mechanism rather than an open-market trade, the executive’s net economic exposure to the company remains essentially unchanged.
AAR Corp. (AIR) Form 144 filing discloses a proposed insider sale of 7,000 common shares—sourced from restricted-stock vesting in 2018-2024—through Morgan Stanley Smith Barney.
- Aggregate market value: $546,509.60
- Shares outstanding: 35,847,589 (sale � 0.02%)
- Planned trade date: 07/23/2025 on the NYSE
- Prior 3-month sales: None reported
- Signer certifies no undisclosed material adverse information
The notice is procedural and does not, by itself, signal operational or financial changes at AAR Corp.
Lumentum Holdings Inc. (LITE) � Form 144 filing discloses that insider Wupen Yuen intends to sell 265 common shares on 07/23/2025 through Morgan Stanley Smith Barney, valued at $26,478.80. The shares were acquired as restricted stock on 07/20/2024. Lumentum has 69.4 million shares outstanding; the proposed sale represents roughly 0.0004 % of total shares, posing no dilution risk.
The filing also lists Yuen’s prior sales over the last three months totaling 14,675 shares for gross proceeds of about $456 k, equal to �0.02 % of shares outstanding. No Rule 10b5-1 plan adoption date is provided. The standard representation states the seller is unaware of undisclosed adverse information.
Overall, the notice signals routine liquidity activity rather than a material corporate event, but it adds to a pattern of modest ongoing insider sales that some investors may monitor for sentiment.
Form 4 overview: On 07/23/2025, AAR Corp. (AIR) director Jennifer L. Vogel executed an open-market sale of 7,000 common shares, coded “S�. The weighted-average sale price was $78.0728, with individual trades ranging from $77.18 to $79.13 (Footnote 1). No derivative securities were involved.
Following the disposition, Vogel’s direct ownership stands at 22,970.002 AIR shares. Based on the disclosed figures, the transaction equates to roughly $0.55 million in gross proceeds and reduces the insider’s direct stake by about 23% (from an estimated 29,970 to 22,970 shares). The filing was signed by attorney-in-fact Katherine Kwiat on the same day, indicating timely compliance with Section 16 reporting requirements.
AAR Corp. (FY ended 31 May 2025) reported strong top-line momentum. Consolidated sales rose $461.6 M, or 19.9%, driven mainly by commercial demand and the late-FY24 Product Support acquisition. Commercial revenue grew $338.2 M (+20.6%); government revenue increased $123.4 M (+18.1%). Segment mix: Parts Supply 40% of sales, Repair & Engineering 32%, Integrated Solutions 25%, Expeditionary Services 3%.
Key portfolio moves included the sale of the Landing Gear Overhaul business to GA Telesis for $48 M, producing a $71.1 M divestiture loss, and a $2.1 M gain on exit of an Indian MRO JV. Integration of FY24’s Product Support buy and FY23’s Trax software investment is yielding cost synergies and digital upselling opportunities.
Growth pipeline: new multi-year distribution deals (Unison, Chromalloy, Ontic), an extended FTAI Aviation USM agreement (CFM56 through 2030) and two U.S. Navy P-8A support contracts. Firm backlog stands at $537.2 M (�75% recognizable in FY26). Airframe MRO capacity is expanding via 114 k sq ft Miami and 80 k sq ft Oklahoma City hangars, targeted for service within 12-18 months (Miami slightly delayed by permitting).
Government exposure remains meaningful: U.S. government agencies and contractors accounted for $687.6 M, 24.7% of revenue. Shares outstanding on 30 Jun 2025 were 35.85 M; non-affiliate market value was ~$2.43 B (11 Nov 2024 close). Workforce totals 5,600 employees and 500 contractors.
FAQ
What is the current stock price of Aar (AIR)?
What is the market cap of Aar (AIR)?
What are the core operating segments of AAR Corp?
How does AAR Corp support commercial aviation?
What services are included under Expeditionary Services?
How does AAR Corp differentiate itself in the industry?
In what ways does AAR Corp demonstrate its industry expertise?
What is the global impact of AAR Corp’s operations?
